Thistle Mary is a director of Entrada Therapeutics Inc.
Person profile
Roles
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Q32 Bio Inc.
27 Mar 24
4
Homology Medicines, Inc.
15 Jun 23
4
Entrada Therapeutics, Inc.
12 Jun 23
4
Vigil Neuroscience, Inc.
9 Jun 23
4
Alaunos Therapeutics, Inc.
8 Jun 23
4
Alaunos Therapeutics, Inc.
24 Jun 22
4
Alaunos Therapeutics, Inc.
24 Jun 22
4
Homology Medicines, Inc.
17 Jun 22
4
Vigil Neuroscience, Inc.
13 Jun 22
4
Entrada Therapeutics, Inc.
6 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Mar 24 | QTTB Q32 Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 16.82 | 12,767 | 214.74 k | 12,767 |
14 Jun 23 | QTTB Q32 Bio | Option Common Stock | Grant | Acquire A | No | No | 1.03 | 23,000 | 23.69 k | 23,000 |
8 Jun 23 | TRDA Entrada Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 14.67 | 16,000 | 234.72 k | 16,000 |
7 Jun 23 | VIGL Vigil Neuroscience | Stock Option Grant Common Stock | Grant | Acquire A | No | No | 10 | 13,928 | 139.28 k | 13,928 |
6 Jun 23 | TCRT Alaunos Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.48 | 100,000 | 48.00 k | 100,000 |